# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-26-063223
Filing Date
2026-05-18
Accepted
2026-05-18 16:27:00
Documents
15
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm266546-1_def14a.htm iXBRL | DEF 14A | 748041
4 | GRAPHIC | lg_alumis-4c.jpg | GRAPHIC | 9028
5 | GRAPHIC | px_26alumispy1pg01-bw.jpg | GRAPHIC | 238018
6 | GRAPHIC | px_26alumispy1pg02-bw.jpg | GRAPHIC | 205664
| Complete submission text file | 0001104659-26-063223.txt |  | 2178022

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | alms-20251231.xsd | EX-101.SCH | 6608
3 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | alms-20251231_lab.xml | EX-101.LAB | 22770
18 | EXTRACTED XBRL INSTANCE DOCUMENT | tm266546-1_def14a_htm.xml | XML | 5720

Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Filer) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-42143 | Film No.: 26993901
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)